- Premature aging in childhood cancer survivors (Review)2023 | 2. lékařská fakulta
- Educational pathways of childhood cancer survivors-a parental cohort2023 | 2. lékařská fakulta
- Subsequent neoplasms in childhood cancer survivors2020 | 2. lékařská fakulta
- Possible mechanisms of subsequent neoplasia development in childhood cancer survivors: A review2021 | 2. lékařská fakulta
- Effect of genetic variation in CYP450 on Gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene approach: Results from the pancareLIFE study2021 | 2. lékařská fakulta
- Is There a Higher Incidence of Sporadic Renal Angiomyolipoma in Childhood Cancer Survivors?2021 | 2. lékařská fakulta, Lékařská fakulta v Plzni
- The Use of Assisted Reproductive Technology by European Childhood Cancer Survivors2022 | 2. lékařská fakulta
- Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE2021 | 2. lékařská fakulta
- Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study2024 | 2. lékařská fakulta
- Health of children born to childhood cancer survivors: Participant characteristics and methods of the Multicenter Offspring Study2021 | 2. lékařská fakulta
- Parenthood for childhood cancer survivors: unfounded fear of cancer development in offspring and related health behaviors2024 | 2. lékařská fakulta
- Tamhane, S., Sfeir, J. G., Kittah, N. E. N., Jasim, S., Chemaitilly, W., Cohen, L. E., Murad, M. H.: Terapie růstovým hormonem u pacientů po nádorovém onemocnění v dětském věku: metaanalýza2019 | 1. lékařská fakulta
- Semen analysis and treatment risk factors in long-term survivors of childhood cancer2021 | 2. lékařská fakulta, Ústřední knihovna
- Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol2018 | 2. lékařská fakulta
- PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents2018 | 2. lékařská fakulta
- Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study2019 | 2. lékařská fakulta
- Isaksson, S., Bogefors, K., Stahl, O., Ebehard, J., Giwercman, L. Y., Leijonhufvud, I., Link, K., Ora, I., Romerius, P., Bobjer, J., Giwercman, A.: Vysoké riziko rozvoje hypogonadismu u mladých mužů po terapii neoplazie2019 | 1. lékařská fakulta
- Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters2016 | 2. lékařská fakulta
- PORUCHY HYBNÉHO SYSTÉMU PACIENTŮ V DLOUHODOBÉ REMISI NÁDOROVÝCH ONEMOCNĚNÍ VZNIKLÝCH V DĚTSKÉM VĚKU /NEFROBLASTOM/Publikace bez příslušnosti k fakultě
- Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence2020 | 3. lékařská fakulta
- Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study2020 | 2. lékařská fakulta
- Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function2021 | 2. lékařská fakulta